Ruud van Beek

2.6k total citations · 1 hit paper
23 papers, 2.0k citations indexed

About

Ruud van Beek is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Ruud van Beek has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Ruud van Beek's work include Influenza Virus Research Studies (20 papers), Respiratory viral infections research (15 papers) and Animal Disease Management and Epidemiology (5 papers). Ruud van Beek is often cited by papers focused on Influenza Virus Research Studies (20 papers), Respiratory viral infections research (15 papers) and Animal Disease Management and Epidemiology (5 papers). Ruud van Beek collaborates with scholars based in Netherlands, United States and Mongolia. Ruud van Beek's co-authors include Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Eric C. J. Claas, J.C. de Jong, Robert G. Webster, Dennis A. Senne, K. F. Shortridge, Scott Krauss, Marianne Baars and Ron A. M. Fouchier and has published in prestigious journals such as The Lancet, Nature Immunology and Journal of Virology.

In The Last Decade

Ruud van Beek

23 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1998 1.1k citations Eric C. J. Claas, Albert D. M. E. Osterhaus et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruud van Beek Netherlands	19	1.7k	803	636	466	296	23	2.0k
Larisa Rudenko Russia	25	1.9k 1.1×	804 1.0×	367 0.6×	659 1.4×	341 1.2×	166	2.2k
Wilina Lim China	11	2.3k 1.4×	1.2k 1.5×	1.1k 1.7×	468 1.0×	256 0.9×	12	2.5k
Amorsolo L. Suguitan United States	21	1.8k 1.1×	668 0.8×	548 0.9×	781 1.7×	258 0.9×	27	2.2k
Laura Campitelli Italy	24	1.3k 0.8×	650 0.8×	846 1.3×	218 0.5×	156 0.5×	41	1.6k
Yun Hee Baek South Korea	23	1.0k 0.6×	984 1.2×	452 0.7×	226 0.5×	416 1.4×	59	1.8k
Salin Chutinimitkul Thailand	18	2.2k 1.3×	1.1k 1.3×	1.0k 1.6×	334 0.7×	386 1.3×	23	2.6k
Jean Hu‐Primmer United States	9	1.6k 1.0×	882 1.1×	742 1.2×	307 0.7×	156 0.5×	11	1.8k
Matthew R. Sandbulte United States	20	1.3k 0.8×	489 0.6×	477 0.8×	458 1.0×	179 0.6×	35	1.6k
Chantal Baas Netherlands	16	1.5k 0.9×	783 1.0×	746 1.2×	541 1.2×	189 0.6×	18	1.9k
Claudia Pappas United States	27	2.7k 1.6×	1.0k 1.3×	1.1k 1.7×	855 1.8×	436 1.5×	56	3.1k

Countries citing papers authored by Ruud van Beek

Since Specialization

Citations

This map shows the geographic impact of Ruud van Beek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruud van Beek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruud van Beek more than expected).

Fields of papers citing papers by Ruud van Beek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruud van Beek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruud van Beek. The network helps show where Ruud van Beek may publish in the future.

Co-authorship network of co-authors of Ruud van Beek

This figure shows the co-authorship network connecting the top 25 collaborators of Ruud van Beek. A scholar is included among the top collaborators of Ruud van Beek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruud van Beek. Ruud van Beek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tannemaat, Martijn R., Robert H.P. de Meel, Jaap Bakker, et al.. (2019). A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis. Vaccine. 37(7). 919–925. 25 indexed citations

Bruin, Erwin de, Mathias Franz, Ortwin Aschenborn, et al.. (2019). Diet May Drive Influenza A Virus Exposure in African Mammals. The Journal of Infectious Diseases. 221(2). 175–182. 10 indexed citations

Mögling, Ramona, Mathilde Richard, Stefan van der Vliet, et al.. (2017). Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by arginine 150 flanking the neuraminidase catalytic site. Journal of General Virology. 98(6). 1274–1281. 33 indexed citations

Baalen, Carel A. van, et al.. (2016). ViroSpot microneutralization assay for antigenic characterization of human influenza viruses. Vaccine. 35(1). 46–52. 46 indexed citations

Fonville, Judith M., Pieter L. A. Fraaij, Gerrie de Mutsert, et al.. (2015). Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection. The Journal of Infectious Diseases. 213(1). 31–38. 33 indexed citations

Backer, Ronald A., Christina Helbig, Rebecca Gentek, et al.. (2014). A central role for Notch in effector CD8+ T cell differentiation. Nature Immunology. 15(12). 1143–1151. 93 indexed citations

Vries, Erhard van der, Anne van der Linden, Jolanda Maaskant, et al.. (2013). Molecular Assays for Quantitative and Qualitative Detection of Influenza Virus and Oseltamivir Resistance Mutations. Journal of Molecular Diagnostics. 15(3). 347–354. 27 indexed citations

Paus, Roelof A. de, Reinout van Crevel, Ruud van Beek, et al.. (2013). The influence of influenza virus infections on the development of tuberculosis. Tuberculosis. 93(3). 338–342. 26 indexed citations

Westgeest, Kim B., Colin A. Russell, Xudong Lin, et al.. (2013). Genomewide Analysis of Reassortment and Evolution of Human Influenza A(H3N2) Viruses Circulating between 1968 and 2011. Journal of Virology. 88(5). 2844–2857. 122 indexed citations

10.

Westgeest, Kim B., Miranda de Graaf, Mathieu Fourment, et al.. (2012). Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution. Journal of General Virology. 93(9). 1996–2007. 66 indexed citations

11.

Meerveld-Eggink, A., Okke de Weerdt, Ankie M.T. van der Velden, et al.. (2011). Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Annals of Oncology. 22(9). 2031–2035. 45 indexed citations

12.

Huijskens, Elisabeth G. W., John W. A. Rossen, Paul Mulder, et al.. (2011). Immunogenicity, Boostability, and Sustainability of the Immune Response after Vaccination against Influenza A Virus (H1N1) 2009 in a Healthy Population. Clinical and Vaccine Immunology. 18(9). 1401–1405. 34 indexed citations

13.

Rimmelzwaan, Guus F., Marianne Baars, Geert van Amerongen, Ruud van Beek, & Albert D. M. E. Osterhaus. (2001). A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses. Vaccine. 20(1-2). 158–163. 37 indexed citations

14.

Brandenburg, A. H., Ruud van Beek, HA Moll, Albert D. M. E. Osterhaus, & Eric C. J. Claas. (2000). G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity. Journal of Clinical Microbiology. 38(10). 3849–3852. 29 indexed citations

15.

Lipatov, A. S., et al.. (2000). Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host.. PubMed. 44(1). 1–8. 28 indexed citations

16.

Rimmelzwaan, Guus F., Marianne Baars, Ruud van Beek, et al.. (1999). Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine. Vaccine. 17(20-21). 2512–2516. 26 indexed citations

17.

Claas, Eric C. J., Albert D. M. E. Osterhaus, Ruud van Beek, et al.. (1998). Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. The Lancet. 351(9101). 472–477. 1150 indexed citations breakdown →

18.

Rimmelzwaan, Guus F., et al.. (1997). Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.. Journal of General Virology. 78(4). 757–765. 82 indexed citations

19.

Claas, Eric C. J., et al.. (1992). Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction. Journal of Virological Methods. 39(1-2). 1–13. 78 indexed citations

20.

Beyer, W.E.P., J. T. M. van der Logt, Ruud van Beek, & N. Masurel. (1986). Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boosting. Journal of Hygiene. 96(3). 513–522. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact